![James Peyer](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profile
James Peyer has held director positions at Aeonian Pharmaceuticals, Inc. and Vita Therapeutics, Inc.
James Peyer active positions
Companies | Position | Start |
---|---|---|
Aeonian Pharmaceuticals, Inc.
![]() Aeonian Pharmaceuticals, Inc. BiotechnologyHealth Technology Aeonian Pharmaceuticals, Inc. operates as a an R&D-stage biopharmaceutical company. It discovers, develops and commercializes innovative therapeutics for the treatment of rare and age-related diseases. The company is headquartered in San Francisco, CA. | Director/Board Member | - |
Vita Therapeutics, Inc.
![]() Vita Therapeutics, Inc. BiotechnologyHealth Technology Vita Therapeutics, Inc. is a biotechnology company based in Baltimore, MD that develops state-of-the-art cellular therapeutics for the treatment of neuromuscular diseases and cancers. The company uses induced pluripotent stem cell (iPSC) technology to engineer specific cell types designed to replace those that are defective in patients. Vita Therapeutics is progressing its co-leading programs VTA-100 and VTA-300 for the treatment of limb-girdle muscular dystrophy (LGMD) and multiple solid tumors with the goal of filing investigational drug applications with the Food and Drug Administration in 2023. The company is developing these proprietary cellular therapies following a dual development strategy beginning with autologous-derived cells before moving to a universal hypoimmunogenic cell line. Vita Therapeutics was founded in 2019 by Douglas Taylor Falk, M.S. and Peter Andersen, Ph.D. Douglas Taylor Falk has been the CEO since 2019. | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Aeonian Pharmaceuticals, Inc.
![]() Aeonian Pharmaceuticals, Inc. BiotechnologyHealth Technology Aeonian Pharmaceuticals, Inc. operates as a an R&D-stage biopharmaceutical company. It discovers, develops and commercializes innovative therapeutics for the treatment of rare and age-related diseases. The company is headquartered in San Francisco, CA. | Health Technology |
Vita Therapeutics, Inc.
![]() Vita Therapeutics, Inc. BiotechnologyHealth Technology Vita Therapeutics, Inc. is a biotechnology company based in Baltimore, MD that develops state-of-the-art cellular therapeutics for the treatment of neuromuscular diseases and cancers. The company uses induced pluripotent stem cell (iPSC) technology to engineer specific cell types designed to replace those that are defective in patients. Vita Therapeutics is progressing its co-leading programs VTA-100 and VTA-300 for the treatment of limb-girdle muscular dystrophy (LGMD) and multiple solid tumors with the goal of filing investigational drug applications with the Food and Drug Administration in 2023. The company is developing these proprietary cellular therapies following a dual development strategy beginning with autologous-derived cells before moving to a universal hypoimmunogenic cell line. Vita Therapeutics was founded in 2019 by Douglas Taylor Falk, M.S. and Peter Andersen, Ph.D. Douglas Taylor Falk has been the CEO since 2019. | Health Technology |
- Stock Market
- Insiders
- James Peyer